Khojasteh Shirkhani

I currently work as a Clinical Project Manager within Professor Adrian Hill’s pre-erythrocytic malaria vaccine group at the Jenner Institute. My role involves providing management support for a new vaccine programme focused on exploring innovative administration regimens for R21, the leading malaria vaccine candidate.

Before this position, I worked as a Clinical Translational Scientist at OxfordBiomedica, where I played a role in supporting and managing the development of cell and gene therapeutic products across various clinical trial phases using bioanalytical assays.

Prior to my role at OxfordBiomedica, I served as a Technical Project Manager at Catalent Pharma Solution. During this time, I led the MACIVIVA project, which aimed to develop a virosome-based vaccine formulation for sublingual delivery targeting HIV.

Before transitioning into Industry, I pursued my Ph.D. in Drug Discovery at Imperial College London.